Skip to main content
Clinical Trials/DRKS00025259
DRKS00025259
Recruiting
N/A

Register study on neuroprognostics in patients with neurological / neurosurgical diseases in intensive care unit - NeuProg

Klinik für Neurologie mit experimenteller Neurologie der Charité Universitätsmedizin Berlin, Campus Charité Mitte0 sites1,700 target enrollmentMay 6, 2021
ConditionsI63I61I67I60S06D33D43C71G00G01G02G03A87A32B05G09A17B00B01B02B45G04G05A81A83A84A85A86A39G60G61G92G70G73G35G36G62G63G64G71G72M60M63M33E88G31G40G93E72G41G12G20G21G23G10F02F00F01F03F04F05F10F13T65Cerebral infarctionIntracerebral haemorrhageOther cerebrovascular diseasesSubarachnoid haemorrhageIntracranial injuryBenign neoplasm of brain and other parts of central nervous systemNeoplasm of uncertain or unknown behaviour of brain and central nervous systemMalignant neoplasm of brainBacterial meningitis, not elsewhere classifiedMeningitis in bacterial diseases classified elsewhereMeningitis in other infectious and parasitic diseases classified elsewhereMeningitis due to other and unspecified causesViral meningitisListeriosisMeaslesSequelae of inflammatory diseases of central nervous systemTuberculosis of nervous systemHerpesviral [herpes simplex] infectionsVaricella [chickenpox]Zoster [herpes zoster]CryptococcosisEncephalitis, myelitis and encephalomyelitisEncephalitis, myelitis and encephalomyelitis in diseases classified elsewhereAtypical virus infections of central nervous systemMosquito-borne viral encephalitisTick-borne viral encephalitisOther viral encephalitis, not elsewhere classifiedUnspecified viral encephalitisMeningococcal infectionHereditary and idiopathic neuropathyInflammatory polyneuropathyToxic encephalopathyMyasthenia gravis and other myoneural disordersDisorders of myoneural junction and muscle in diseases classified elsewhereMultiple sclerosisOther acute disseminated demyelinationOther polyneuropathiesPolyneuropathy in diseases classified elsewhereOther disorders of peripheral nervous systemPrimary disorders of musclesOther myopathiesMyositisDisorders of muscle in diseases classified elsewhereDermatopolymyositisOther metabolic disordersOther degenerative diseases of nervous system, not elsewhere classifiedEpilepsyOther disorders of brainOther disorders of amino-acid metabolismStatus epilepticusSpinal muscular atrophy and related syndromesParkinson diseaseSecondary parkinsonismOther degenerative diseases of basal gangliaHuntington diseaseDementia in other diseases classified elsewhereDementia in Alzheimer diseaseVascular dementiaUnspecified dementiaOrganic amnesic syndrome, not induced by alcohol and other psychoactive substancesDelirium, not induced by alcohol and other psychoactive substancesMental and behavioural disorders due to use of alcoholMental and behavioural disorders due to use of sedatives or hypnoticsToxic effect of other and unspecified substances

Overview

Phase
N/A
Intervention
Not specified
Conditions
I63
Sponsor
Klinik für Neurologie mit experimenteller Neurologie der Charité Universitätsmedizin Berlin, Campus Charité Mitte
Enrollment
1700
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 6, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Neurologie mit experimenteller Neurologie der Charité Universitätsmedizin Berlin, Campus Charité Mitte

Eligibility Criteria

Inclusion Criteria

  • 18 years and older
  • \- Neurointensive medical condition requiring monitoring in the neurointensive care unit or stroke unit. This applies to patients with the following diagnoses: ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhages, neurovascular malformations, craniocerebral trauma, brain tumours, Infectious diseases of the nervous system (pathogen\-induced meningitis/encephalitis), neuromuscular diseases (e.g. myastenia grasvis, Lambert\-Eaton syndrome), Various autoimmune neurological diseases (e.g. autoimmune encephalitis, multiple sclerosis, myelitis, neuromyelitis optica, inflammatory neuropathies (GBS, CIDP), myopathies/myositis), Metabolic or genetic neurological diseases, Hypoxic\-ischaemic encephalopathies after cardiac arrest, Metabolic encephalopathies, Seizure disorders (status epilepticus, other epileptic seizures), Neurodegenerative diseases (e.g. ALS, Parkinson's disease, multisystem atrophies, Huntington's disease), Quantitative and qualitative disorders of consciousness (e.g. delirium), Intoxications
  • \- Consent by the patient or the patient's legal representative

Exclusion Criteria

  • \- Simultaneous participation in an interventional drug or medical device study.
  • \- Known contraindications to MRI (pacemakers, neurostimulators, metal splinters, cochlear implant, claustrophobia)

Outcomes

Primary Outcomes

Not specified

Similar Trials